For instance, even if the HBM market more than doubled to $8.9B in 2024, the HBM market would still account for a relatively small portion of the memory market, which is expected to total $120B in 2024.

Source: https://seekingalpha.com/article/4635619-formfactor-stock-why-the-tug-of-war-could-continue?source=feed_all_articles

For instance, even if the HBM market more than doubled to $8.9B in 2024, the HBM market would still account for a relatively small portion of the memory market, which is expected to total $120B in 2024.

Source: https://seekingalpha.com/article/4635619-formfactor-stock-why-the-tug-of-war-could-continue?source=feed_all_articles

HBM has evolved from a research tool to detect toxic exposures in occupational and environmental exposures to include financially lucrative applications designed to augment sports performance to superhuman capacity.

Source: https://sfbayview.com/2023/01/navigating-the-toxic-triangle-in-bayview-hunters-point-2023/?utm_source=rss&utm_medium=rss&utm_campaign=navigating-the-toxic-triangle-in-bayview-hunters-point-2023

In early December HBM withdrew its license application for Batoclimab, citing delays in Phase III clinical trials, and said it would reapply in the first half of 2024, with a knock-on effect on revenue.

Source: https://seekingalpha.com/article/4659164-hbm-gets-health-boost-from-drug-licensing-deals?source=feed_all_articles